Recent News

• 06.05.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
• 05.29.2025 - Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
• 05.20.2025 - H.C. Wainwright 3rd Annual BioConnect Investor Conference
• 05.19.2025 - SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
• 05.19.2025 - SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology
• 05.13.2025 - Lexicon Pharmaceuticals 1st Quarter 2025 Results Conference Call
• 05.13.2025 - Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.13.2025 - Lexicon Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.06.2025 - Lexicon Pharmaceuticals to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conference

Recent Filings

• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - 8-K Current report
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors